Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Simulations Plus Inc (SLP)

Simulations Plus Inc (SLP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 971,671
  • Shares Outstanding, K 19,985
  • Annual Sales, $ 59,580 K
  • Annual Income, $ 9,960 K
  • 60-Month Beta 0.75
  • Price/Sales 16.06
  • Price/Cash Flow 57.80
  • Price/Book 5.40
Trade SLP with:

Options Overview Details

View History
  • Implied Volatility 56.13% ( +2.43%)
  • Historical Volatility 33.37%
  • IV Percentile 92%
  • IV Rank 82.97%
  • IV High 64.25% on 06/25/24
  • IV Low 16.52% on 08/14/23
  • Put/Call Vol Ratio 0.47
  • Today's Volume 72
  • Volume Avg (30-Day) 20
  • Put/Call OI Ratio 0.14
  • Today's Open Interest 311
  • Open Int (30-Day) 305

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 05/31/24
See More
  • Average Estimate 0.17
  • Number of Estimates 1
  • High Estimate 0.17
  • Low Estimate 0.17
  • Prior Year 0.20
  • Growth Rate Est. (year over year) -15.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
44.48 +9.31%
on 06/05/24
50.11 -2.97%
on 06/13/24
-1.13 (-2.27%)
since 05/28/24
3-Month
37.75 +28.79%
on 04/03/24
51.22 -5.08%
on 05/15/24
+7.47 (+18.15%)
since 03/28/24
52-Week
32.69 +48.73%
on 10/27/23
52.69 -7.72%
on 08/08/23
+5.40 (+12.49%)
since 06/28/23

Most Recent Stories

More News
Jobs Report Highlighted During Holiday-Shortened Week

Monday U.S. Economic Lookahead S&P final U.S. manufacturing PMI (June) Construction ...

DDD : 3.07 (unch)
DZSI : 1.1700 (-13.33%)
PXD : 269.62 (+0.73%)
MSM : 79.31 (+1.67%)
SLP : 48.62 (+1.55%)
RDUS : 15.27 (+4.30%)
STZ : 257.28 (+0.54%)
KALV : 11.78 (-2.24%)
Simulations Plus: Fiscal Q2 Earnings Snapshot

Simulations Plus: Fiscal Q2 Earnings Snapshot

SLP : 48.62 (+1.55%)
Simulations Plus: Fiscal Q1 Earnings Snapshot

Simulations Plus: Fiscal Q1 Earnings Snapshot

SLP : 48.62 (+1.55%)
Simulations Plus: Fiscal Q4 Earnings Snapshot

Simulations Plus: Fiscal Q4 Earnings Snapshot

SLP : 48.62 (+1.55%)
Simulations Plus: Fiscal Q3 Earnings Snapshot

Simulations Plus: Fiscal Q3 Earnings Snapshot

SLP : 48.62 (+1.55%)
Happy National Holidays

Monday U.S. Economic Lookahead ISM Manufacturing (June) Construction Spending ...

CULP : 4.48 (+0.90%)
SLP : 48.62 (+1.55%)
NUMI.TO : 0.0450 (unch)
RCH.TO : 41.19 (+1.13%)
ATZ.TO : 38.72 (+2.87%)
Simulations Plus Receives U.S. FDA Renewal for DILIsym Software Licenses

Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today announced that the U.S. FDA has renewed its licenses...

SLP : 48.62 (+1.55%)
Simulations Plus: Fiscal Q2 Earnings Snapshot

Simulations Plus: Fiscal Q2 Earnings Snapshot

SLP : 48.62 (+1.55%)
Simulations Plus Reports Second Quarter Fiscal 2023 Financial Results

Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today reported financial results for its second quarter...

SLP : 48.62 (+1.55%)
MIDD+ 2023 Panelists Discuss How to Increase Gender Equity for Women in Science

More than 150 people from around the world gathered virtually this past February for a panel discussion about how to move the needle on gender equity for women in science.

SLP : 48.62 (+1.55%)

Business Summary

Simulations Plus, Inc., is a premier developer of groundbreaking drug discovery and development simulation software, which is licensed to and used in the conduct of drug research by major pharmaceutical and biotechnology companies worldwide. They have two other businesses, Words+, Inc. and FutureLab,...

See More

Key Turning Points

3rd Resistance Point 51.00
2nd Resistance Point 50.36
1st Resistance Point 49.49
Last Price 48.62
1st Support Level 47.98
2nd Support Level 47.33
3rd Support Level 46.46

See More

52-Week High 52.69
Last Price 48.62
Fibonacci 61.8% 45.05
Fibonacci 50% 42.69
Fibonacci 38.2% 40.33
52-Week Low 32.69

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar